Mingyuan Medicare Development Company Limited is an investment holding company. The Company is engaged in commercializing diagnostics technologies and is a supplier of biomedical solutions in China. As of December 31, 2010, it sold more than 15 million protein chips for cancer screening. The Company鈥檚 segments include Product, Manufacturing and Distribution (PMD), which is involved in vitro diagnostic products (IVD) and consists of the Protein Chips Division and the Healthcare Division; Medical Centres Management (MCM), which represents the business of health screening and management, and Bio Drugs business unit, which is based on biomedical drugs. MCM also provides a new and direct sales channel for the Company鈥檚 IVD products. The Company's healthcare division consists of two units, Hospital Unit and the Cervical Cancer Care Unit. Under the Hospital Unit, it manages the Shanghai Woman and Child Healthcare Hospital of Hong-Kou District.